Skip to main content

Table 1 Baseline demographics and ocular characteristics of participants

From: Combination of Ranibizumab with macular laser for macular edema secondary to branch retinal vein occlusion: one-year results from a randomized controlled double-blind trial

Variables

IVR (N = 30)

IVR + Laser (N = 34)

P value

Age, years

59.6 ± 11.0

58.4 ± 9.7

0.6392

Gender, male

17 (56.7%)

18 (52.9%)

0.7651

Ischemic

11 (36.7%)

16 (47.1%)

0.4009

BCVA

59.3 ± 8.3

54.4 ± 9.8

0.0384*

CRT (μm)

516.1 ± 161.1

571.6 ± 223.5

0.2647

SBP (mmHg)

136.9 ± 11.6

131.5 (127, 140)

0.3457

DBP (mmHg)

79.3 ± 8.7

79.4 ± 10.8

0.9548

Intraocular pressure (mmHg)

16.2 ± 2.3

15.5 ± 2.6

0.2919

  1. BCVA best corrected visual acuity, CRT central retinal thickness, SBP systolic blood pressure, DBP diastolic blood pressure
  2. *P < 0.05